GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hoechst Pakistan Ltd (KAR:HPL) » Definitions » Capital Expenditure

Hoechst Pakistan (KAR:HPL) Capital Expenditure : ₨-364.54 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Hoechst Pakistan Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Hoechst Pakistan's cash flow for capital expenditures for the three months ended in Mar. 2024 was ₨-135 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ₨-364.54 Mil.


Hoechst Pakistan Capital Expenditure Historical Data

The historical data trend for Hoechst Pakistan's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hoechst Pakistan Capital Expenditure Chart

Hoechst Pakistan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -392.01 -485.37 -307.10 -573.23 -286.73

Hoechst Pakistan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -56.85 -40.17 -77.67 -112.04 -134.66

Hoechst Pakistan Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨-364.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hoechst Pakistan (KAR:HPL) Business Description

Traded in Other Exchanges
N/A
Address
Korangi Industrial Area, Plot 23, Sector 22, Karachi, PAK, 74900
Hoechst Pakistan Ltd Formerly Sanofi-Aventis Pakistan Ltd is engaged in the manufacturing and selling of pharmaceutical and consumer healthcare products and vaccines. Its product profile includes Oral Anti-Diabetics, Emergency Care, Antibiotics, Anti-malaria, Epilepsy, Sleep Disorders, and others. Geographically, the company operates in Pakistan, Afghanistan, and others.

Hoechst Pakistan (KAR:HPL) Headlines

No Headlines